THE CANNABINOID EXPERTS
EUROPE´S FIRST CANNABIS TECH COMPANY!
MIND Bioscience is a Cannabis Tech Company delivering innovative cannabinoids for breakthrough therapies based on cannabinoid receptor pharmacology. Unique in both Europe and the USA, MIND Bioscience is a successful combination of biotechnology, chemistry and bioinformatics.
$ 50 B
pharma market opportunity by 2029
70 Cannabinoids
largest library on the market
20 years experience
in cannabinoids and syntheses
3 headed
serial entrepreneur founding team
Stay up to date
Latest News
PROFILE
The world’s first Cannabis-Tech Company combining biotechnology, chemistry and bioinformatics disciplines to develop and deliver innovative cannabinoids for breakthrough therapies based on cannabinoid receptor pharmacology.
CONTACT
MIND Bioscience GmbH
Emil-Figge-Straße 76a
44227 Dortmund
GERMANY
E-Mail: info@mindbioscience.com
Telefon: +49 231 226198 98